Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;13(1):189-203.
doi: 10.1007/s13300-021-01188-7. Epub 2021 Dec 20.

Are There Different Viewpoints About the Management of Type 2 Diabetes Mellitus and Comorbidities? A Multidisciplinary Spanish Qualitative Research

Affiliations

Are There Different Viewpoints About the Management of Type 2 Diabetes Mellitus and Comorbidities? A Multidisciplinary Spanish Qualitative Research

Francesc-Xavier Cos et al. Diabetes Ther. 2022 Jan.

Abstract

Introduction: The aim of this study was to explore the vision of a large multidisciplinary group of physicians treating type 2 diabetes mellitus (T2DM) in Spain, with a special focus on controversial management aspects. The perceptions of primary care (PC) physicians and hospital care (HC) specialists were compared.

Methods: This was a mixed survey that included Delphi-like statements and opinion, attitude and behaviour (OAB) questions. The Delphi-like statements were assessed on the basis of the degree of agreement among respondents, and a descriptive analysis was performed on the answers to the OAB questions.

Results: A total of 296 participants responded to the first wave of the survey, of whom 293 responded to the second wave (211 from PC and 80 from HC, with two respondents for whom there were no data on specialty). A high degree of consensus (CNS ≥ 0.8) was obtained in all the statements. A proactive approach to detect prediabetes or T2DM in asymptomatic people was highly supported (80.4% of agreement). Introducing early treatment intensification was considered to favour the durability of glycaemic control and to delay the progression of the disease (80.4%). There was agreement on the statement that glycaemic variability constitutes a risk factor for chronic complications, although differences in the perceptions of HC physicians and PC specialists were identified (86.3 vs. 80.1%, respectively). More HC physicans than PC specialists considered comorbidities to affect the ability to self-care (95 vs. 82.9%, respectively).

Conclusions: The survey revealed that there was a high, albeit not universal, degree of agreement amongst PC physicians and HC specialists in relation to prevention, screening and diagnosis of T2DM; early treatment intensification; dysglycaemias; and the management of patients with comorbidities. The statement on the management of patients with comorbidities elicited the highest difference between PC physicans and HC specialists. The results of this survey indicate that there is room for improvement in terms of implementing strategies in these areas.

Keywords: Antidiabetic agents; Clinical guidelines; Comorbidities; Diabetes Mellitus, type 2; Drug therapy, combination; Prediabetes; Primary care; Qualitative research.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Percentage of agreement obtained for Delphi statements (N = 291 participants)
Fig. 2
Fig. 2
Questions on opinion, attitude and behaviour (OAB) regarding strict glycaemic control (N = 296)
Fig. 3
Fig. 3
OAB questions on early treatment intensification (N = 296)
Fig. 4
Fig. 4
OAB questions on the risk of hypoglycaemia (N = 296)

References

    1. Aschner P, Beck-Nielsen H, Bennett P, et al. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104:1–52. - PubMed
    1. Gómez-Peralta F, Abreu C, Cos X, Gómez-Huelgas R. When does diabetes start? Early detection and intervention in type 2 diabetes mellitus. Rev Clin Esp. 2020;220:305–314. - PubMed
    1. Ceriello A, Gavin JR, Boulton AJM, et al. The Berlin Declaration: a call to action to improve early actions related to type 2 diabetes. How can specialist care help? Diabetes Res Clin Pract. 2018;139:392–399. - PubMed
    1. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;2018:17. - PMC - PubMed
    1. Schnell O, Standl E, Cos X, et al. Report from the 5th cardiovascular outcome trial (CVOT) summit. Cardiovasc Diabetol. 2020;19:1–10. - PMC - PubMed

LinkOut - more resources